Get 40% Off
🤯 This Tech Portfolio is up 29% YTD! Join Now to Get April’s Top PicksGet The Picks – Just 99 USD

Why NetEase Shares Are Trading Lower; Here Are 25 Stocks Moving Premarket

Published 17/11/2022, 12:49
Updated 17/11/2022, 14:10
© Reuters.  Why NetEase Shares Are Trading Lower; Here Are 25 Stocks Moving Premarket

© Reuters. Why NetEase Shares Are Trading Lower; Here Are 25 Stocks Moving Premarket

Benzinga - Gainers

  • Ardelyx Inc (NASDAQ: ARDX) shares rose 81.2% to $2.21 in pre-market trading as the company said the FDA Advisory Committee voted 9-To-4 that the benefits of XPHOZAH outweigh its risks for the control of serum phosphorus in adult patients with chronic kidney disease on dialysis.
  • Elevate Credit, Inc. (NYSE: ELVT) shares rose 65.1% to $1.75 in pre-market trading after the company agreed to be acquired by Park Cities Asset Management in an all-cash transaction at an implied value of $67 million.
  • Cuentas Inc. (NASDAQ: CUEN) rose 29.6% to $0.3239 in pre-market trading after dropping 28% on Wednesday. Cuentas authorized a share repurchase program.
  • Bath & Body Works, Inc. (NYSE: BBWI) rose 22.3% to $38.09 in pre-market trading after the company reported better-than-expected Q3 results and raised FY22 earnings forecast.
  • SomaLogic, Inc. (NASDAQ: SLGC) rose 14.5% to $3.08 in pre-market trading. The company recently posted upbeat Q3 results and raised FY22 revenue guidance.
  • The9 Limited (NASDAQ: NCTY) rose 10.8% to $0.9105 in pre-market trading. The9 is scheduled to hold its annual general meeting on December 19, 2022.
  • Companhia Energética de Minas Gerais (NYSE: CIG) shares jumped 10.3% to $2.14 in pre-market trading following a 3% decline in the previous session.
  • Cartesian Growth Corporation (NASDAQ: GLBL) rose 10.1% to $9.48 in pre-market trading after dropping over 15% on Wednesday.
  • Satsuma Pharmaceuticals, Inc. (NASDAQ: STSA) rose 9.8% to $0.67 in pre-market trading. BML Investment Partners LP reported a 19.4% passive stake in Satsuma Pharmaceuticals as of November 14.
  • Bit Brother Limited (NASDAQ: BTB) rose 9.1% to $0.1699 in pre-market trading after declining over 5% on Wednesday.
  • Skillz Inc. (NYSE: SKLZ) rose 7.5% to $1.15 in pre-market trading after dropping 10% on Wednesday.
  • Cisco Systems (NASDAQ:CSCO), Inc. (NASDAQ: CSCO) rose 4% to $46.16 in pre-market trading after the company reported better-than-expected Q1 results.

Don’t forget to check out our premarket coverage here .

Losers

  • Fast Radius, Inc. (NASDAQ: FSRD) shares fell 23.2% to $0.1613 in pre-market trading on continued volatility after the company recently established a timeline for a Chapter 11 sale process. The company’s stock jumped 106% on Wednesday.
  • Bionomics Limited (NASDAQ: BNOX) fell 15.1% to $7.20 in pre-market trading after the company reported pricing of underwritten offering of 641,026 American Depositary Shares in the U.S. at a price of $7.80 per ADS.
  • SenesTech, Inc. (NASDAQ: SNES) shares fell 13.5% to $2.81 in pre-market trading. SenesTech reported pricing of $5 million public offering.
  • Vaccitech plc (NASDAQ: VACC) fell 10% to $2.17 in pre-market trading. Vaccitech recently posted Q3 EPS of $0.22.
  • Ensysce Biosciences, Inc. (NASDAQ: ENSC) shares fell 9.2% to $2.53 in pre-market trading after surging 29% on Wednesday.
  • Ormat Technologies, Inc. (NYSE: ORA) fell 8.9% to $91.25 in pre-market trading. Ormat reported pricing of upsized public offering of 3.75 million shares of common stock on behalf of stockholder ORIX Corporation at a price of $90 per share.
  • Esports Entertainment Group, Inc. (NASDAQ: GMBL) fell 8.9% to $0.1275 in pre-market trading after jumping around 12% on Wednesday.
  • Blue Water Vaccines, Inc. (NASDAQ: BWV) shares fell 8.2% to $1.12 in pre-market trading after dropping 9% on Wednesday.
  • Perfect Corp. (NYSE: PERF) fell 8% to $8.22 in pre-market trading after dipping 10% on Wednesday.
  • Sensus Healthcare, Inc. (NASDAQ: SRTS) fell 7.8% to $6.70 in pre-market trading after dropping 7% on Wednesday.
  • Sunshine Biopharma, Inc. (NASDAQ: SBFM) fell 7.3% to $0.7730 in pre-market trading. Sunshine Biopharma recently entered into a collaboration agreement with a North American lipid nanoparticle (LNP) company to advance the development of its mRNA-based anticancer macromolecule, K1.1.
  • Flotek Industries, Inc. (NYSE: FTK) shares fell 6.6% to $0.99 in pre-market trading. Flotek Industries recently posted a Q3 loss of $0.25 per share.
  • NetEase (NASDAQ:NTES), Inc. (NASDAQ: NTES) shares fell 5.6% to $67.35 in pre-market trading after the company reported weak quarterly sales.
© 2022 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.

Read the original article on Benzinga

Latest comments

Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2024 - Fusion Media Limited. All Rights Reserved.